166 related articles for article (PubMed ID: 2897515)
1. Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis.
Schwartz B; Al-Tobaiqi A; Al-Ruwais A; Fontaine RE; A'ashi J; Hightower AW; Broome CV; Music SI
Lancet; 1988 Jun; 1(8597):1239-42. PubMed ID: 2897515
[TBL] [Abstract][Full Text] [Related]
2. [Alternating rifampicin and ceftriaxone for Neisseria meningitidis eradication in contacts].
Shehab S; Leitner L; Bogokowsky B; Epstein I; Swartz TA
Harefuah; 1991 Jun; 120(11):641-3. PubMed ID: 1937208
[TBL] [Abstract][Full Text] [Related]
3. Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections.
Schwartz B
Rev Infect Dis; 1991; 13 Suppl 2():S170-3. PubMed ID: 2017647
[TBL] [Abstract][Full Text] [Related]
4. Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin.
Cuevas LE; Kazembe P; Mughogho GK; Tillotson GS; Hart CA
J Infect Dis; 1995 Mar; 171(3):728-31. PubMed ID: 7876629
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease.
Jackson LA; Alexander ER; DeBolt CA; Swenson PD; Boase J; McDowell MG; Reeves MW; Wenger JD
Pediatr Infect Dis J; 1996 Nov; 15(11):992-8. PubMed ID: 8933547
[TBL] [Abstract][Full Text] [Related]
6. Antibiotics for preventing meningococcal infections.
Fraser A; Gafter-Gvili A; Paul M; Leibovici L
Cochrane Database Syst Rev; 2006 Oct; (4):CD004785. PubMed ID: 17054214
[TBL] [Abstract][Full Text] [Related]
7. The effect of rifampicin on meningococcal carriage in family contacts in northern Nigeria.
Blakebrough IS; Gilles HM
J Infect; 1980 Jun; 2(2):137-43. PubMed ID: 6821084
[No Abstract] [Full Text] [Related]
8. Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis.
Simmons G; Jones N; Calder L
J Antimicrob Chemother; 2000 Jun; 45(6):909-11. PubMed ID: 10837450
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics for preventing meningococcal infections.
Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L
Cochrane Database Syst Rev; 2011 Aug; (8):CD004785. PubMed ID: 21833949
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: emergence of resistant strains.
Weidmer CE; Dunkel TB; Pettyjohn FS; Smith CD; Leibovitz A
J Infect Dis; 1971 Aug; 124(2):172-8. PubMed ID: 5001453
[No Abstract] [Full Text] [Related]
11. Antibiotics for preventing meningococcal infections.
Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004785. PubMed ID: 24163051
[TBL] [Abstract][Full Text] [Related]
12. Failure of mass antibiotic prophylaxis to control a prolonged outbreak of meningococcal disease in an Israeli village.
Shehab S; Keller N; Barkay A; Leitner L; Leventhal A; Block C
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):749-53. PubMed ID: 9923513
[TBL] [Abstract][Full Text] [Related]
13. Management of a rifampicin-resistant meningococcal infection in a teenager.
Delaune D; Andriamanantena D; Mérens A; Viant E; Aoun O; Ceppa F; Taha MK; Rapp C
Infection; 2013 Jun; 41(3):705-8. PubMed ID: 23408002
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of rifampicin in the treatment of Meningococcus carriers].
Borgoño JM; Rodríguez H; García J; Cánepa I
Rev Chil Pediatr; 1981; 52(2):146-8. PubMed ID: 6792661
[No Abstract] [Full Text] [Related]
15. [The use of rifampicin in healthy carriers of "N. meningitidis" (author's transl)].
Delia S; Mauro A; Miceli MT
Ann Sclavo; 1978; 20(5):675-80. PubMed ID: 111629
[No Abstract] [Full Text] [Related]
16. Group A meningococcal carriage in travelers returning from Saudi Arabia.
Moore PS; Harrison LH; Telzak EE; Ajello GW; Broome CV
JAMA; 1988 Nov; 260(18):2686-9. PubMed ID: 3184335
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics for preventing meningococcal infections.
Fraser A; Gafter-Gvili A; Paul M; Leibovici L
Cochrane Database Syst Rev; 2005 Jan; (1):CD004785. PubMed ID: 15674966
[TBL] [Abstract][Full Text] [Related]
18. Meningococcal infection: evidence for school transmission.
Wall R; Wilson J; MacArdle B; Vellani Z
J Infect; 1991 Sep; 23(2):155-9. PubMed ID: 1753114
[TBL] [Abstract][Full Text] [Related]
19. Chemoprophylaxis for Neisseria meningitidis in an isolated Arctic community.
Nicolle LE; Postl B; Kotelewetz E; Remillard F; Bourgault AM; Albritton W; Harding GK; Ronald A
J Infect Dis; 1982 Jan; 145(1):103-9. PubMed ID: 6798128
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effect of Rifampin on the nasopharyngeal carriage of Neisseria meningitidis. A preliminary report.
Beam WE; Newberg NR; Devine LF
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):316-20. PubMed ID: 4996195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
